Clin2
NCT07428330Possibly a fitRecruiting

HPV self-testing to improve cervical cancer screening for women with HIV

Cervix CancerHIV InfectionsHPV Infection

Part of Cancer, Immune system & allergy, Infections, Women’s health & pregnancy clinical trials.

This trial compares two ways to help women with HIV get screened for cervical cancer: a clinic-based approach versus a combined clinic and community outreach program. You may be able to provide samples yourself at a clinic or at home to test for HPV, the virus that can cause cervical cancer.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
7,597 people
Ages
25 years to 49 years
Study type
Interventional

Who can take part

  • You are a woman living with HIV
  • You are between 25 and 49 years old (or as recommended by Uganda's health guidelines)
  • You have never had cervical cancer screening, or you are due for HPV testing now, or you had HPV testing before and need a follow-up, or you had treatment for cervical cell changes more than a year ago and haven't been screened since
  • You attend a clinic that provides HIV care and antiretroviral therapy
  • You have not had your cervix removed, are not pregnant or within 3 months after giving birth, have not been told you need follow-up for an abnormal screening that you didn't complete, and have never been treated for invasive cervical cancer

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07624123Not yet recruiting
Home HPV Testing vs Clinic Visits for Cervical Cancer Screening in Women With HIV

This study compares two ways to screen women with HIV for cervical cancer: using a self-collection test at home versus visiting a clinic. The goal is to make cervical cancer screening easier and reach more women who might otherwise skip it.

Harare
NCT05173324Not yet recruiting· Phase 3
HPV vaccine plus cervical screening for women with HIV

This trial tests whether adding HPV vaccination to the cervical cancer screening plan—while you get care at HIV (ARV) clinics—improves prevention of cervical problems. It focuses on women with HIV aged 25–35 to help reduce HPV-related cervical disease over time.

NCT06619743Not yet recruiting
HPV and vaginal health in women with HIV

This study looks at HPV infection and the natural balance of bacteria in the vagina in women with HIV. It aims to understand how these factors affect health and may guide future prevention or treatment.

NCT07336134Recruiting
HPV self-test for cervical health

This study offers a way to screen for cervical cancer using an HPV self-test. It is designed for women who may not have had a recent Pap smear and are from certain minority groups.

Philadelphia, Pennsylvania
NCT07576842Not yet recruiting
HPV Screening strategies for women with HIV

This study tests different ways to screen for HPV (a virus linked to cervical cancer) in women living with HIV. The goal is to find the best, most practical screening approach to catch cervical problems early.

Gaborone, South-East District
NCT07520188Not yet recruiting
Improving cervical cancer screening for women with HIV

This study aims to make cervical cancer screening easier and more accessible for women living with HIV. Researchers will test new ways to help women get screened and receive follow-up care at three clinics across the United States.

Atlanta, Georgia

Hear when a new Cervix Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.